✦ LIBER ✦

A Multiple-Ascending-Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK-875, in Subjects With Type 2 Diabetes

✍ Scribed by Leifke, E; Naik, H; Wu, J; Viswanathan, P; DeManno, D; Kipnes, M; Vakilynejad, M

Book ID: 120399888
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 324 KB
Volume: 92
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.2012.43

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, Tolerability, Pharmacokinetics,

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of the GPR40 Agonist TAK-875: Results From a Double-Blind, Placebo-Controlled Single Oral Dose Rising Study in Healthy Volunteers

✍ Naik, Himanshu; Vakilynejad, Majid; Wu, Jingtao; Viswanathan, Prabhakar; Dote, N 📂 Article 📅 2012 🏛 Sage Publications 🌐 English ⚖ 220 KB

A Placebo-Controlled, Multiple Ascending

A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects

✍ Randy Dockens, Jun-Sheng Wang, Lorna Castaneda, Oleksandr Sverdlov, Shu-Pang Hua 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 542 KB

A placebo-controlled, ascending, multipl

A placebo-controlled, ascending, multiple-dose study to evaluate the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS-708163 in healthy young and elderly subjects

✍ Wang, Jun-Sheng; Castaneda, Lorna; Sverdlov, Alex; Huang, Shu-Pang; Slemmon, Ran 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Safety, pharmacokinetics and pharmacodyn

Safety, pharmacokinetics and pharmacodynamics of multiple-ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitus

✍ L. A. Morrow; M. Leonsson-Zachrisson; H. Ericsson; M. Wollbratt; M. Knutsson; M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 909 KB

Safety, tolerability, pharmacokinetics a

Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus

✍ Seino, Yutaka; Nakajima, Hiromu; Miyahara, Hajime; Kurita, Takashi; Bush, Mark A 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 230 KB

A Phase 1, dose escalation study to eval

A Phase 1, dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple oral daily doses of ELND006 in healthy elderly subjects

✍ Liang, Earvin; Liu, Wenzhong Jerry; Lohr, Lisa; Nguyen, Van; Lin, Holly; Munson, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB